Northeast Endocrine Metabolic Associates — Philadelphia, Pennsylvania

Northeast Endocrine Metabolic Associates is a clinical research site located in Philadelphia, Pennsylvania, United States 19114-1028.

Crixeo Clinical Trials Trust Score: 14/100 (FAILING). This profile has not yet been claimed by the site owner.

Northeast Endocrine Metabolic Associates has participated in 4 clinical trials with 2 currently active.

Therapeutic areas: Kidney Disease, Chronic, Obesity, Type 2 Diabetes.

Sponsors: Boehringer Ingelheim, Novo Nordisk A/S, Eli Lilly and Company.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Philadelphia

Browse all research sites in Pennsylvania · View every site in Philadelphia

Sponsor Feasibility Report

Trust Score: 14/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Northeast Endocrine Metabolic Associates?

Northeast Endocrine Metabolic Associates has a Crixeo Trust Score of 14/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Northeast Endocrine Metabolic Associates conducted?

Northeast Endocrine Metabolic Associates has 4 clinical trials on record, with 2 currently active. Their work covers Kidney Disease, Chronic, Obesity, Type 2 Diabetes.

Is Northeast Endocrine Metabolic Associates accredited by Crixeo Clinical Trials?

Northeast Endocrine Metabolic Associates has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Northeast Endocrine Metabolic Associates?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.